FOXC2
Forkhead box protein C2
Also known as: FKHL14, FOXC2_HUMAN, MFH-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99958
- Gene
- FOXC2
- Ensembl
- ENSG00000176692
- Chromosome
- 16
- Canonical length
- 501 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nuclear bodies
OverviewNCBI Gene
This gene belongs to the forkhead family of transcription factors which is characterized by a distinct DNA-binding forkhead domain. The specific function of this gene has not yet been determined; however, it may play a role in the development of mesenchymal tissues. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
501 residues, UniProt reviewed canonical sequence.
>Q99958|FOXC2
1 MQARYSVSDP NALGVVPYLS EQNYYRAAGS YGGMASPMGV YSGHPEQYSA GMGRSYAPYH
61 HHQPAAPKDL VKPPYSYIAL ITMAIQNAPE KKITLNGIYQ FIMDRFPFYR ENKQGWQNSI
121 RHNLSLNECF VKVPRDDKKP GKGSYWTLDP DSYNMFENGS FLRRRRRFKK KDVSKEKEER
181 AHLKEPPPAA SKGAPATPHL ADAPKEAEKK VVIKSEAASP ALPVITKVET LSPESALQGS
241 PRSAASTPAG SPDGSLPEHH AAAPNGLPGF SVENIMTLRT SPPGGELSPG AGRAGLVVPP
301 LALPYAAAPP AAYGQPCAQG LEAGAAGGYQ CSMRAMSLYT GAERPAHMCV PPALDEALSD
361 HPSGPTSPLS ALNLAAGQEG ALAATGHHHQ HHGHHHPQAP PPPPAPQPQP TPQPGAAAAQ
421 AASWYLNHSG DLNHLPGHTF AAQQQTFPNV REMFNSHRLG IENSTLGESQ VSGNASCQLP
481 YRSTPPLYRH AAPYSYDCTK YLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FOXC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.65
- Highest tissue expression
- 37 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 37 nTPM
- kidney: 5.5 nTPM
- heart muscle: 4.8 nTPM
- adipose tissue: 2 nTPM
- salivary gland: 2 nTPM
- pituitary gland: 1.9 nTPM
Single-cell type
- lymphatic endothelial cells: 81 nCPM
- vascular smooth muscle cells: 69 nCPM
- peritubular myoid cells: 36 nCPM
- pericytes: 24 nCPM
- podocytes: 23 nCPM
- ocular epithelial cells: 23 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 7 nTPM
- cerebral cortex: 3.6 nTPM
- basal ganglia: 2.4 nTPM
- cerebellum: 1.9 nTPM
- spinal cord: 1.5 nTPM
- thalamus: 1.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FOXC2.
Disease | AllUniProt
Conditions FOXC2 is implicated in, by any mechanism.
- Lymphedema-distichiasis syndrome (LPHDST) MIM:153400
Disease | GeneticClinVar
58 pathogenic / likely-pathogenic of 305 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Distichiasis-lymphedema syndrome
- FOXC2-related disorder
- Non-immune hydrops fetalis
- Inborn genetic diseases
- LYMPHEDEMA-DISTICHIASIS SYNDROME WITH RENAL DISEASE AND DIABETES MELLITUS
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.79
- gnomAD pLI
- 0.13
- gnomAD missense Z
- -0.25
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anatomical structure morphogenesis
- apoptotic process involved in outflow tract morphogenesis
- artery morphogenesis
- blood vessel diameter maintenance
- blood vessel remodeling
- branching involved in blood vessel morphogenesis
- camera-type eye development
- cardiac muscle cell proliferation
- cell differentiation
- collagen fibril organization
- embryonic heart tube development
- embryonic viscerocranium morphogenesis
- glomerular endothelium development
- glomerular mesangial cell development
- heart development
- insulin receptor signaling pathway
- lymphangiogenesis
- mesoderm development
- metanephros development
- negative regulation of apoptotic process involved in outflow tract morphogenesis
- negative regulation of cold-induced thermogenesis
- negative regulation of transcription by RNA polymerase II
- neural crest cell development
- Notch signaling pathway
- ossification
- paraxial mesodermal cell fate commitment
- podocyte differentiation
- positive regulation of cell adhesion mediated by integrin
- positive regulation of cell migration involved in sprouting angiogenesis
- positive regulation of DNA-templated transcription
- positive regulation of endothelial cell migration
- positive regulation of transcription by RNA polymerase II
- positive regulation of vascular wound healing
- regulation of organ growth
- regulation of transcription by RNA polymerase II
- response to hormone
- somitogenesis
- ureteric bud development
- vascular endothelial growth factor receptor signaling pathway
- ventricular cardiac muscle tissue morphogenesis
Molecular functions
- chromatin DNA binding
- DNA-binding transcription activator activity
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- identical protein binding
- promoter-specific chromatin binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- transcription cis-regulatory region binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FOXC2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FOXC2 as an antibody target. Whether an autoantibody or antibody against FOXC2 could matter depends on whether native FOXC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FOXC2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FOXC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...